TOXBAR
LIVE

Serial Number

99369694

Owner

Athena Medtec Limited

Attorney

John Mueller

Filing Date

Sep 2, 2025

Add to watchlist:

No watchlists yet
View on USPTO

TOXBAR Trademark

Serial Number: 99369694

TOXBAR is a trademark filed by Athena Medtec Limited on September 2, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Athena Medtec Limited (2 trademarks)

4 Langley Avenue
Surrey KT6 6QL , GB

Entity Type: 99

Trademark Details

Filing Date

September 2, 2025

Registration Date

Not Registered

Goods & Services

Medical preparations in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical preparations in the nature of a gel substance injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Medical preparations in the nature of a gel barrier product used to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.

Medical devices, namely, surgical implants made of synthetic materials in the nature of a hyaluronic acid based barrier substance injected between the prostate and rectum to mitigate the toxicity effects of radiotherapy treatments of prostate cancer; Medical devices, namely, surgical implants made of synthetic materials in the nature of a gel injected between the prostate and rectum for creating a space between the two for protecting the rectum from radiation during prostate cancer radiation treatment; Kits for use in medical and surgical procedures comprising applicators in the nature of injection needles and a hyaluronic acid based substance for medical use; surgical and medical apparatus and instruments for use in injecting a gel between an organ at risk and an organ with cancer creating a space between the two for protecting the organ at risk from radiation during radiotherapy treatment for the organ with cancer; Medical apparatus in the nature of a medical barrier device used to create a space between the prostate and the rectal wall to minimise the risk of radiation toxicity impacting on the rectum during radiotherapy treatment for prostate cancer.

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 16, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 16, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jul 16, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 15, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 8, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 8, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 22, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 22, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 22, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 2, 2025 MAFR
NEW APPLICATION ENTERED
Sep 2, 2025 NWAP